Description
Ketro-Eye Eye Drops for Dogs and Cats – Fast Relief from Eye Pain & Inflammation
Protect your pet’s delicate eyes with Ketro-Eye Eye Drops for Dogs and Cats, a trusted ophthalmic solution formulated to relieve pain, inflammation, and redness associated with various eye conditions. Powered by Ketorolac Tromethamine, a non-steroidal anti-inflammatory drug (NSAID), Ketro-Eye provides effective relief from ocular discomfort without the use of steroids.
Available at Pettivo.com, Ketro-Eye Eye Drops are commonly recommended by veterinarians for managing inflammatory eye conditions in both dogs and cats, including post-operative eye care and allergic irritation.
✅ Key Benefits of Ketro-Eye Eye Drops
- Contains Ketorolac Tromethamine for powerful anti-inflammatory action
- Reduces redness, swelling, and eye irritation
- Helps relieve ocular pain and discomfort
- Useful in post-surgical eye care
- Steroid-free formulation
- Suitable for both dogs and cats
🐶🐱 Indications
Ketro-Eye Eye Drops are commonly used for:
- Allergic conjunctivitis
- Non-infectious inflammatory eye conditions
- Post-operative ocular inflammation
- Redness and swelling of the eyes
- Mild ocular irritation
💧 How It Works
Ketorolac works by inhibiting prostaglandin synthesis, which reduces inflammation and pain in the affected eye. This targeted mechanism helps your pet feel comfortable while supporting recovery.
📌 Usage Directions
- Clean the eye area gently before application.
- Instill the prescribed number of drops as advised by your veterinarian.
- Follow the complete course and dosage instructions.
For veterinary use only. Use strictly under veterinary guidance.
🛒 Why Buy Ketro-Eye from Pettivo.com?
- Genuine veterinary ophthalmic products
- Safe and secure online ordering
- Fast delivery across India
- Dedicated pet healthcare support
Choose Ketro-Eye Eye Drops for Dogs and Cats to ensure fast, effective relief from eye inflammation and discomfort, helping your furry companions stay active and comfortable.




Reviews
There are no reviews yet.